1834 Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-125
Closed -$4K 368
2022
Q2
$4K Hold
125
﹤0.01% 416
2022
Q1
$4K Hold
125
﹤0.01% 398
2021
Q4
$4K Sell
125
-245
-66% -$7.98K ﹤0.01% 430
2021
Q3
$12K Sell
370
-383
-51% -$12.3K ﹤0.01% 383
2021
Q2
$23K Buy
+753
New +$24.8K ﹤0.01% 348

Other funds holding OGN

1834 Investment Advisors's OGN Position: Q3 2022 in Review

1834 Investment Advisors sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 125 shares — an estimated $4K sold.

1834 Investment Advisors first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $23K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • 1834 Investment Advisors reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • 1834 Investment Advisors sold 125 Organon & Co shares in Q3 2022, an estimated $4K.
  • 1834 Investment Advisors first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • 1834 Investment Advisors's Organon & Co position peaked at $23K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.